Uniphar PLC
ISEQ:UPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Petrotal Corp
LSE:PTAL
|
US |
|
A
|
Access Group Holdings Co Ltd
TSE:7042
|
JP |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IE |
U
|
Uniphar PLC
ISEQ:UPR
|
1B EUR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
106.5B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.6B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.9B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -6 913.1% |
| 30th Percentile | 0% |
| Median | 3.1% |
| 70th Percentile | 10.2% |
| Max | 197.7% |
Other Profitability Ratios
Uniphar PLC
Glance View
Uniphar Plc engages in the provision of pre-wholesale and wholesale pharmaceutical distribution. The company is headquartered in Dublin, Dublin and currently employs 2,920 full-time employees. The company went IPO on 2019-07-17. The firm is a diversified healthcare services company. The company serves multinational pharmaceutical and medical technology manufacturers across three divisions: Commercial & Clinical, Product Access and Supply Chain & Retail. Through commercial & clinical division, the Company provides sales, marketing and distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Product Access division offers two service offerings: On Demand Access and Exclusive Access. On Demand Access is a pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists. Exclusive Access is a manufacturer led solution for controlling the release of specialty medicines for specifically approved patient populations. Supply Chain & Retail provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare and animal health products.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Uniphar PLC is 1.7%, which is below its 3-year median of 1.9%.
Over the last 3 years, Uniphar PLC’s Net Margin has decreased from 2.2% to 1.7%. During this period, it reached a low of 1.7% on Jan 1, 2026 and a high of 2.3% on Dec 31, 2024.
